Trial intelligence / Profile preview

Lidocaine for muscle relaxation and postoperative inflammation in type 2 diabetes

ChiCTR2000034148Phase 4Recruiting

Sponsor
Baoying County People's Hospital
Start
Jun 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of lidocaine in type 2 diabetes mellitus (T2DM) (4 arms), sponsored by Baoying County People's Hospital. Primary endpoints: Onset time, Maintenance dosage per unit time and 6 more. Started Jun 2020; status: recruiting.

02

Drugs

lidocaine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on ChiCTR2000034148.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000034148.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call